Formation and characterization of the nanoparticle-protein corona.
暂无分享,去创建一个
Iseult Lynch | Marco P Monopoli | Andrzej S Pitek | Kenneth A Dawson | K. Dawson | I. Lynch | A. S. Pitek | M. Monopoli
[1] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[2] Albert Duschl,et al. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. , 2011, Small.
[3] M. Zheng,et al. Ethylene glycol monolayer protected nanoparticles: synthesis, characterization, and interactions with biological molecules. , 2004, Langmuir : the ACS journal of surfaces and colloids.
[4] Richard J. Simpson,et al. Proteins and proteomics : a laboratory manual , 2003 .
[5] Mingdi Yan,et al. Synthetic polymer nanoparticle-polysaccharide interactions: a systematic study. , 2012, Journal of the American Chemical Society.
[6] Kenneth A. Dawson,et al. Transferrin Coated Nanoparticles: Study of the Bionano Interface in Human Plasma , 2012, PloS one.
[7] Albert Duschl,et al. Time evolution of the nanoparticle protein corona. , 2010, ACS nano.
[8] Graham B. I. Scott,et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.
[9] Istvan Toth,et al. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.
[10] Kenneth A. Dawson,et al. Nanobiotechnology: nanoparticle coronas take shape. , 2011, Nature nanotechnology.
[11] Kenneth A. Dawson,et al. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. , 2012, ACS nano.
[12] Stefan Tenzer,et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.
[13] Kenneth A. Dawson,et al. Protein–Nanoparticle Interactions , 2008, Nano-Enabled Medical Applications.
[14] Judith Klein-Seetharaman,et al. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. , 2012, ACS nano.
[15] Jau-Song Yu,et al. Comprehensive proteomic analysis of mineral nanoparticles derived from human body fluids and analyzed by liquid chromatography-tandem mass spectrometry. , 2011, Analytical biochemistry.
[16] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[17] Roberto Cingolani,et al. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. , 2010, ACS nano.
[18] Claus-Michael Lehr,et al. Atomic force microscopy and analytical ultracentrifugation for probing nanomaterial protein interactions. , 2012, ACS nano.
[19] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[20] Darren J. Martin,et al. Differential plasma protein binding to metal oxide nanoparticles , 2009, Nanotechnology.
[21] M. Mahmoudi,et al. Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.
[22] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[23] Iseult Lynch,et al. What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.
[24] Ronald J. Moore,et al. Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size , 2011, Proteomics.
[25] K. Dawson,et al. The protein corona of dendrimers: PAMAM binds and activates complement proteins in human plasma in a generation dependent manner , 2012 .
[26] Minnamari Vippola,et al. Proteomic characterization of engineered nanomaterial-protein interactions in relation to surface reactivity. , 2011, ACS nano.
[27] Andrzej S Pitek,et al. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.
[28] T. Xia,et al. Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.
[29] Parag Aggarwal,et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[30] Warren C W Chan,et al. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. , 2012, Chemical Society reviews.
[31] C. Fan,et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. , 2011, ACS nano.
[32] R. Zhou,et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity , 2011, Proceedings of the National Academy of Sciences.